益生菌降低终末期肾脏疾病蛋白结合毒素的研究进展
<正>随着社会老龄化及糖尿病、高血压等慢性疾病发病率升高,全球慢性肾脏病(chronic kidney disease,CKD)患病人数逐年增加<sup>[1]</sup>。根据最新流行病学调查显示,我国成年人群中CKD的患病率为10.8%,据此估计我国现有成年CKD患者1.2亿<sup>[2]</sup>。大量CKD患者随着病程发展进展为终末期肾病(end stage renal disease,ESRD),预后较差。欧洲肾脏协会及欧洲透析移植协会(ERA-EDTA)统计数据显示,65<sup>7</sup>...
Saved in:
| Main Authors: | 陈旭娇, 陈思秀, 毛志国 |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2015-01-01
|
| Series: | Linchuang shenzangbing zazhi |
| Online Access: | http://www.lcszb.com/thesisDetails?columnId=57919978&Fpath=home&index=0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
终末期肾脏疾病遗传易感性研究进展
Published: (2013-01-01) -
蛋白结合毒素与慢性肾脏病及其心血管并发症
by: 赵景宏
Published: (2017-01-01) -
终末期肾病患者的透析时机
by: 张景红
Published: (2017-01-01) -
终末期肾病患者认知功能障碍的发生机制与干预策略新进展
by: 刘俊, et al.
Published: (2023-01-01) -
分泌型卷曲蛋白4、分泌型卷曲蛋白5与糖尿病肾脏疾病患者血管钙化的关系
by: 高冬梅, et al.
Published: (2023-01-01)